Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-003015
Filing Date
2025-08-22
Accepted
2025-08-22 16:05:14
Documents
1
Period of Report
2025-08-22

Document Format Files

Seq Description Document Type Size
1 6-K zk2533691.htm 6-K 9965
  Complete submission text file 0001178913-25-003015.txt   11195
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 251246260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)